How to structure a company towards an IPO or tradesale
Rainer Kreifels ist Referent zum Thema "How to structure a company towards an IPO or tradesale" beim Biotech & Finance Forum 2006.
Preparing an IPO or Tradesale requires different preparations and
structuring of the business. How can a company create a structure that keeps
both IPO and tradesale options open without hindering the progression and growth
of the business? At some point a decision will have to be made either way. When
is that point, and what restructuring of the business is then required to take
the company towards each of the exit routes?
The Biotech & Finance Forum has established
itself as THE pan-European initiative allowing innovative biotech and life
science businesses from across Europe to meet in a very pragmatic and direct way
with an extensive audience of Europe's leading life sciences and biotech
investors as well as senior executives from top pharmaceutical firms. As a long
running initiative of the European Commission, the BFF is organised by Europe
Unlimited in association with EuropaBio. ▪ www.e-unlimied.com
Veranstaltung: Europe Unlimited ▪ Biotech & Finance Forum
Fachgebiete:
Corporate & Compliance, Mergers & Acquisitions
Branche:
Life Science & Biotech
